Uncontrolled hypercalcemia or symptomatic hypercalcemia requiring continued use of bisphosphonate therapy;
Uncontrolled tumor-related pain, or uncontrolled hypercalcemia or clinically significant (symptomatic) hypercalcemia
History of hypercalcemia
Uncontrolled or symptomatic hypercalcemia
Uncontrolled disease-related metabolic disorder (e.g., hypercalcemia);
Uncontrolled hypercalcemia
Hypercalcemia
Uncontrolled hypercalcemia
History of either symptomatic hypercalcemia or hyperparathyroidism, at the treating investigators discretion
Hypercalcemia
Uncontrolled hypercalcemia
< Grade  hypo/hypercalcemia
Uncontrolled hypercalcemia
Uncontrolled hypercalcemia or symptomatic hypercalcemia requiring continued use of bisphosphonate therapy or denosumab
Uncontrolled or symptomatic hypercalcemia
Uncontrolled hypercalcemia or symptomatic hypercalcemia requiring continued use of bisphosphonate therapy or denosumab General Medical Exclusion Criteria:
Uncontrolled or symptomatic hypercalcemia
History of hypercalcemia
History of clinically significant hypercalcemia
Uncontrolled hypercalcemia
Uncontrolled hypercalcemia
Symptomatic hypercalcemia
The patient has hypercalcemia.
The patient has hypercalcemia.
Uncontrolled hypercalcemia
Uncontrolled hypercalcemia
Subjects with hypercalcemia (> . mg/dL)
Uncontrolled hypercalcemia or symptomatic hypercalcemia requiring continued use of bisphosphonate therapy
Known hypercalcemia
Uncontrolled or symptomatic hypercalcemia
Patients with hypercalcemia or kidney stones
Uncontrolled tumour-related pain or hypercalcemia
